跳至主要内容
临床试验/NCT05049629
NCT05049629终止不适用

Effect of Chitosan-N-Acetylcysteine (Lacrimera®) on IOL-power Prior to Cataract Surgery: a Pilot Study

Vienna Institute for Research in Ocular Surgery2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
30
试验地点
2
主要终点
Difference in spherical and toric IOL power

研究概览

简要总结

Aim of this study is to evaluate the effect of treatment with Lacrimera® on calculated IOL power prior to cataract surgery and on the stability of ocular surface parameters compared to preservative-free, Hyaluronic-acid containing eyedrops (Hylo-Vision® sine).

详细描述

The present study seeks to investigate the effect of treatment with Lacrimera® on the calculated IOL power prior to cataract surgery and on the stability of ocular surface parameters compared to preservative-free, Hyaluronic-acid containing eyedrops (Hylo-Vision® sine).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

盲法说明

All study-related measurements will be performed by a masked observer.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age older than 18 years
  • Corneal staining (marked to severe; NEI grading scale >=10)

排除标准

  • Usage of eye drops other than lubricants (e.g. antibiotics, steroids, cyclosporin-A)
  • Usage of systemic antibiotic therapy 7
  • Any pathology of the ocular surface except dry eye disease (e.g. corneal scarring, cornea ectasia)
  • Ocular surgery within prior 3 months
  • Preceding refractive surgery (e.g. LASIK)
  • Ocular injury within prior 3 months
  • Ocular herpes of eye or eyelid within prior 3 months
  • Active ocular infection
  • Active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
  • Eyelid abnormalities that affect lid function
  • Ocular surface abnormality that may compromise corneal integrity
  • Pregnancy and nursing women (in women of childbearing age a pregnancy test will be performed before inclusion into the study)

结局指标

主要结局

Difference in spherical and toric IOL power

时间窗: 2 weeks

Difference in spherical and toric IOL power between baseline and the 2 weeks visit

Spherical and toric IOL power

时间窗: 2 weeks

Spherical and toric IOL power selected at the 2 weeks visit

次要结局

  • Reproducibility of biometry readings(2 weeks +/- 2 days)
  • Difference between study and control eye(2 weeks +/- 2 days)
  • Change of dry eye parameters(2 weeks +/- 2 days)

研究者

发起方
Vienna Institute for Research in Ocular Surgery
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prim. Prof. Dr. Oliver Findl, MBA

Principal Investigator

Vienna Institute for Research in Ocular Surgery

研究点 (2)

Loading locations...

相似试验